Head of the GMMG Studygroup, Department of Medicine V
Department of Medicine V, University Hospital Heidelberg; and National Center for Tumor Diseases (NCT)
Heidelberg, Germany
Since October 2022 Professor Hartmut Goldschmidt is leading the German-speaking Myeloma Multicenter Group (GMMG) – Study Group at the University Hospital Heidelberg.
Since March of 2021 he has been representing the newly founded GMMG e.V. Association in his role as President.
During the time period 2005 – 2022 Professor Goldschmidt was the Head of the Section Multiple Myeloma, Medical Hospital V, University Hospital Heidelberg and the National Center of Tumor Diseases.
After his graduation from medical school and his licensing as a practicing physician in 1982, he received the conferment of doctorate in 1984 at the Humboldt-University in Berlin. In 1988 he was recognized as consultant for internal medicine and worked as assistant physician at the University Medical Center for the Internal Medicine, Charité Hospital in Berlin. In 1991 he was recognized in the field of “hematology and internal oncology”. In 1997 he qualified as a professor at the Ruprecht-Karls-University in Heidelberg and was subsequently employed there from 1999 through 2005 as leading senior physician. In June of 2018 he accepted the W3 endowed professorship “Translational Myeloma Research” at the University Clinic in Heidelberg. In February 2018 he was awarded the German Cancer Award for Clinical Cancer Research.
Abstract Session 1: MRD and risk stratification
Wednesday, September 27, 2023
5:45 PM – 6:45 PM EEST